The upregulation of PD-L1 expression after radiotherapy has been found to negatively regulate the antitumor immune response of T cells by interacting with the PD-1 protein, leading to the expression of an immune-negative regulatory axis that promotes HCC invasion [8–10]. This evidence concerns the gene CD274 and hepatocellular carcinoma.